Christianson Mark's most recent trade in NeuroOne Medical Technologies Corp was a trade of 253 Common Stock done at an average price of $0.9 . Disclosure was reported to the exchange on Sept. 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.89 per share. | 30 Sep 2025 | 253 | 230,985 | - | 0.9 | 225 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Sale of securities on an exchange or to another person at price $ 0.74 per share. | 05 Sep 2025 | 30,000 | 231,238 | - | 0.7 | 22,203 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.68 per share. | 30 Jun 2025 | 253 | 261,238 | - | 0.7 | 172 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Sale of securities on an exchange or to another person at price $ 0.58 per share. | 04 Jun 2025 | 10,000 | 261,491 | - | 0.6 | 5,804 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Sale of securities on an exchange or to another person at price $ 0.62 per share. | 21 May 2025 | 8,967 | 271,491 | - | 0.6 | 5,586 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Sale of securities on an exchange or to another person at price $ 0.64 per share. | 21 May 2025 | 14 | 280,458 | - | 0.6 | 9 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Sale of securities on an exchange or to another person at price $ 0.67 per share. | 19 May 2025 | 8,006 | 283,485 | - | 0.7 | 5,330 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Sale of securities on an exchange or to another person at price $ 0.66 per share. | 19 May 2025 | 3,013 | 280,472 | - | 0.7 | 1,976 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2025 | 200,000 | 200,000 | - | - | Option to Purchase Common Stock | |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.85 per share. | 31 Mar 2025 | 253 | 291,491 | - | 0.8 | 215 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.16 per share. | 18 Feb 2025 | 1,812 | 291,744 | - | 1.2 | 2,102 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.16 per share. | 31 Jan 2025 | 90 | 293,556 | - | 1.2 | 104 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.83 per share. | 31 Dec 2024 | 343 | 293,646 | - | 0.8 | 283 | Common Stock |
| NeuroOne Medical Tech Corp | Christianson Mark | Business Development Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.62 per share. | 30 Nov 2024 | 90 | 293,989 | - | 0.6 | 56 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.97 per share. | 31 Oct 2024 | 90 | 294,079 | - | 1.0 | 87 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.99 per share. | 30 Sep 2024 | 343 | 294,169 | - | 1.0 | 340 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.80 per share. | 31 Aug 2024 | 90 | 294,512 | - | 0.8 | 72 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.76 per share. | 31 Jul 2024 | 90 | 294,602 | - | 0.8 | 68 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.80 per share. | 30 Jun 2024 | 343 | 294,692 | - | 0.8 | 274 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Sale of securities on an exchange or to another person at price $ 0.88 per share. | 06 Jun 2024 | 2,189 | 295,035 | - | 0.9 | 1,918 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Sale of securities on an exchange or to another person at price $ 0.88 per share. | 05 Jun 2024 | 25,800 | 297,224 | - | 0.9 | 22,663 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.93 per share. | 31 May 2024 | 90 | 323,024 | - | 0.9 | 84 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.13 per share. | 30 Apr 2024 | 90 | 323,114 | - | 1.1 | 102 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.15 per share. | 21 Apr 2024 | 2,030 | 323,204 | - | 1.2 | 2,335 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.20 per share. | 31 Mar 2024 | 90 | 325,234 | - | 1.2 | 108 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.21 per share. | 29 Feb 2024 | 90 | 325,324 | - | 1.2 | 109 | Common Stock |
| NeuroOne Medical Tech Corp | Christianson Mark | Business Development Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2024 | 25,000 | 325,414 | - | 0 | Common Stock | |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.26 per share. | 31 Jan 2024 | 90 | 300,414 | - | 1.3 | 113 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.58 per share. | 31 Dec 2023 | 90 | 300,504 | - | 1.6 | 142 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Sale of securities on an exchange or to another person at price $ 1.46 per share. | 26 Dec 2023 | 31,445 | 300,594 | - | 1.5 | 45,859 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Sale of securities on an exchange or to another person at price $ 1.35 per share. | 26 Dec 2023 | 6,848 | 332,039 | - | 1.4 | 9,269 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Sale of securities on an exchange or to another person at price $ 1.40 per share. | 21 Dec 2023 | 9,907 | 340,687 | - | 1.4 | 13,870 | Common Stock |
| NeuroOne Medical Tech Corp | Christianson Mark | Business Development Director | Sale of securities on an exchange or to another person at price $ 1.40 per share. | 21 Dec 2023 | 1,800 | 338,887 | - | 1.4 | 2,520 | Common Stock |
| NeuroOne Medical Tech Corp | Christianson Mark | Business Development Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.46 per share. | 30 Nov 2023 | 90 | 350,594 | - | 1.5 | 131 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.02 per share. | 31 Jul 2023 | 90 | 351,044 | - | 1.0 | 92 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.20 per share. | 30 Jun 2023 | 90 | 351,134 | - | 1.2 | 108 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.21 per share. | 31 May 2023 | 90 | 351,224 | - | 1.2 | 109 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.54 per share. | 30 Apr 2023 | 90 | 351,314 | - | 1.5 | 139 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Apr 2023 | 14,000 | 351,404 | - | 0 | Common Stock | |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Apr 2023 | 14,000 | 14,000 | - | - | Option to Purchase Common Stock | |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.61 per share. | 31 Mar 2023 | 90 | 337,404 | - | 1.6 | 145 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Sale of securities on an exchange or to another person at price $ 1.50 per share. | 21 Mar 2023 | 12,711 | 337,494 | - | 1.5 | 19,092 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Sale of securities on an exchange or to another person at price $ 1.51 per share. | 21 Mar 2023 | 11,667 | 350,205 | - | 1.5 | 17,600 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Sale of securities on an exchange or to another person at price $ 1.60 per share. | 21 Mar 2023 | 2,122 | 361,872 | - | 1.6 | 3,405 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share. | 03 Feb 2023 | 2,175 | 363,994 | - | 1.5 | 3,197 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 15,000 | 366,169 | - | 0 | Common Stock | |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Sale of securities on an exchange or to another person at price $ 6.74 per share. | 23 Jun 2021 | 11,300 | 1,077,906 | - | 6.7 | 76,200 | Common Stock |
| NeuroOne Medical Tech Corp | Mark Christianson | Business Development Director | Sale of securities on an exchange or to another person at price $ 6.30 per share. | 23 Jun 2021 | 600 | 1,077,306 | - | 6.3 | 3,780 | Common Stock |